Description

tert-Butyl 7,7-Dimethyl-6,7-Dihydro-1H-Pyrazolo[4,3-C]Pyridine-5(4H)-Carboxylate is a high-purity, advanced pharmaceutical intermediate featuring a complex fused heterocyclic structure. This compound is of significant value for its role as a key building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring sophisticated molecular scaffolds. It is primarily sought after by research institutions and pharmaceutical manufacturers engaged in the development of new drug candidates.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the multi-step synthesis of complex drug molecules, especially those targeting the central nervous system (CNS) and oncology.
• Medicinal Chemistry Research: Used as a versatile scaffold for structure-activity relationship (SAR) studies and the exploration of new chemical entities in drug discovery programs.
• API Synthesis: Integral in the production route for final active pharmaceutical ingredients that incorporate the pyrazolopyridine core, known for its potential biological activity.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and process development for the pharmaceutical industry.
• Chemical Reference Standard: Can be utilized as a high-purity analytical standard for quality control and method development in pharmaceutical analysis.

Basic Information

Item	Details
Product Name	tert-Butyl 7,7-Dimethyl-6,7-Dihydro-1H-Pyrazolo[4,3-C]Pyridine-5(4H)-Carboxylate
CAS No.	635712-88-8
Molecular Formula	C13H21N3O2
Molecular Weight	251.33 g/mol
Synonyms	tert-Butyl 7,7-dimethyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine-5-carboxylate; 5-tert-Butoxycarbonyl-7,7-dimethyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine; 7,7-Dimethyl-5,6,7,8-tetrahydro-1H-pyrazolo[4,3-c]pyridine-5-carboxylic acid tert-butyl ester; BOC-protected 7,7-dimethyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine; 635712-88-8
EINECS	Contact for details

Quality Control

Our tert-Butyl 7,7-Dimethyl-6,7-Dihydro-1H-Pyrazolo[4,3-C]Pyridine-5(4H)-Carboxylate is manufactured under strict quality management systems. Every batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical R&D and production. Comprehensive Certificates of Analysis (COA) with detailed chromatographic data are provided to guarantee traceability and batch-to-batch consistency.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep the container tightly sealed to protect from moisture.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.